Researchers at the University of Toronto have found a way to better control the preclinical generation of key neurons ...

A new organoid model of the dopaminergic system sheds lights on its intricate functionality and potential implications for Parkinson's disease. In this interview, Dr. Church, the Molecular and ...

A one-time treatment for Parkinson’s disease could be a ‘market changer,’ experts told BioSpace, adding that cell therapies ...

In sum, this phase 2 trial showed that lixisenatide, administered in an on-medication state, had a three-point improvement on ...

Motor dysfunction, a hallmark of Parkinson's, is caused by the progressive loss of dopaminergic neurons in the midbrain. Lysosomes, organelles that function as recycling plants inside cells ...

Global Parkinson’s Disease Industry likely to raise at a CAGR of 5.1% and may surpass US$ 3.7 billion during forecast period ...

Figure 2: Colocalization of Ptx3 protein and Lmx1b transcripts in mesencephalic dopaminergic neurons. Figure 6: Expression of Lmx1b in sagittal sections of Nurr1 knockout (−/−) animals ...

Senescent cells displayed more proinflammatory, metabolically deregulated, and pathology-associated signatures ...

Medications enhancing dopaminergic tone include amantadine, bupropion, and stimulants, with yohimbine showing noradrenergic effects. Among the reported antidotes, the only 2 without ...

The rainy season is here and it comes with a lot of goodies. You get to see fruits and lots of vegetables. Crassocephalum crepidioides\xa0 (Ebolo), Crassocephalum Biafra (Worowo), Amaranthus viridis ...

A pipeline candidate from NurrOn Pharmaceuticals (originating from Harvard Medical School's Molecular Neurobiology Laboratory ...